European guidelines for breast cancer treatment

Aromatase gene amplification

Personalised medicine for rare cancers

Clinical potential of trastuzumab biosimilar CTP6

ASCO 2017: Round up

Updates in melanoma: Treating BRAF and brain metastases

Bendamustine for indolent lymphoma reduces relapse after 10 years

ShortHER trastuzumab treatment of HER2 breast cancer: 9 weeks v 1 year

T-VEC and checkpoint therapy for melanoma

Dacomitinib for EGFR positive lung cancer

Treating advanced melanoma with ipilimumab and HF10

Alectinib eclipses crizotinib for ALK positive lung cancer